跳至主要内容
临床试验/JPRN-UMIN000006987
JPRN-UMIN000006987招募中未知

A prospective study to evaluate the efficacy and safety of pregabalin for triweekly abraxane-induced peripheral neuralgia - Pregabalin for abraxane-induced peripheral neuralgia

Kinki University Faculty of Medicine0 个研究点目标入组 30 人开始时间: 2011年12月29日最近更新:
适应症

试验速览

阶段
未知
状态
招募中
发起方
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Contraindication to abraxane and pregabalin 2. Creatinine clearance less than 30mL/min 3. With previous history of pregabalin administration 4. With unstable dosage of antidepressant drugs at 3 weeks of registration 5. With serious drug allergy 6. With severe complications 7. Pregnant or nursing women 8. With peripheral neuropathy caused by other drugs 9. Determination as contraindication by doctors

研究者

发起方
Kinki University Faculty of Medicine

相似试验